Search Ontology:
ChEBI

avanafil

Term ID
CHEBI:66876
Synonyms
  • (S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide
  • 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
  • avanafil
  • Stendra
Definition
A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidine-5-carboxylic acid with the amino group of pyrimidin-2-ylmethylamine. Used for treatment of erectile dysfunction.
References
  • cas:330784-47-9
  • drugcentral:4305
  • kegg.drug:D03217
  • patent:EP1366760
  • patent:US6403597
  • pubmed:18197727
  • pubmed:18491987
  • pubmed:20637970
  • pubmed:20939743
  • pubmed:21745238
  • pubmed:21905762
  • pubmed:22087063
  • pubmed:22248153
  • pubmed:22384456
  • pubmed:22448738
  • pubmed:22704456
  • pubmed:22759639
  • pubmed:22788525
  • reaxys:11746013
  • wikipedia.en:Avanafil
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from avanafil
Phenotype where environments contain avanafil
Phenotype modified by environments containing avanafil
Phenotype affecting avanafil
Human Disease Model